Catalyst Pharmaceuticals CPRX reported adjusted earnings of 68 cents per share for the third quarter of 2025, beating the ...

Pacira BioSciences (PCRX) faces Exparel generic threats in 2024. Learn about risks, portfolio strategy shifts, and key ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

FMC Corporation faces severe challenges from high leverage, macro headwinds, and the expiration of a key product patent. Read ...

Boots is being sued by a travel accessories company that claims travel pillows sold by the UK retailer imitate its “particularly ergonomic” design and breach its intellectual property rights.